Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Veterinary Medicine
Volume 2018, Article ID 9078537, 6 pages
https://doi.org/10.1155/2018/9078537
Case Report

Injectable Chemotherapy Downstaged Oral Squamous Cell Carcinoma from Nonresectable to Resectable in a Rescue Dog: Diagnosis, Treatment, and Outcome

1HylaPharm LLC, 2029 Becker Drive, Lawrence, KS 66047, USA
2University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160, USA
3State Line Animal Hospital, Leawood, KS 66206, USA
4University of Kansas, 2095 Constant Ave., Lawrence, KS 66047, USA

Correspondence should be addressed to Marcus Laird Forrest; ude.uk@tserrofl

Received 2 May 2018; Accepted 13 September 2018; Published 8 October 2018

Academic Editor: Sheila C. Rahal

Copyright © 2018 Shuang Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Cohen, S. Cai, Y. Xie, and M. L. Forrest, “A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo,” The American Journal of Surgery, vol. 198, no. 6, pp. 781–786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. O. Venable, D. R. Worley, D. L. Gustafson et al., “Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomas,” American Journal of Veterinary Research, vol. 73, no. 12, pp. 1969–1973, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Cai, T. Zhang, W. C. Forrest et al., “Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors,” American Journal of Veterinary Research, vol. 77, no. 9, pp. 1005–1016, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Knapp, R. C. Richardson, P. L. Bonney, and K. Hahn, “Cisplatin therapy in 41 dogs with malignant tumors,” Journal of Veterinary Internal Medicine, vol. 2, no. 1, pp. 41–46, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Shapiro, B. E. Kitchell, T. W. Fossum, C. G. Couto, and G. Theilen, “Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs,” Journal of the American Veterinary Medical Association, vol. 193, no. 12, pp. 1530–1533, 1988. View at Google Scholar
  6. S. M. Cohen, N. Rockefeller, R. Mukerji et al., “Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma,” JAMA Otolaryngology–Head & Neck Surgery, vol. 139, no. 4, pp. 382–387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Cai, Y. Xie, N. M. Davies, M. S. Cohen, and M. L. Forrest, “Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head neck,” Therapeutic Delivery, vol. 1, no. 2, pp. 237–245, 2010. View at Publisher · View at Google Scholar
  8. S. M. Cohen, R. Mukerji, S. Cai, I. Damjanov, M. L. Forrest, and M. S. Cohen, “Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo,” The American Journal of Surgery, vol. 202, no. 6, pp. 646–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Q. Yang, D. J. Aires, S. Cai et al., “In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma,” Journal of Drugs in Dermatology (JDD), vol. 13, no. 3, pp. 283–287, 2014. View at Google Scholar · View at Scopus
  10. S. Ishiguro, S. Cai, D. Uppalapati et al., “Intratracheal administration of hyaluronan-cisplatin conjugate nanoparticles significantly attenuates lung cancer growth in mice,” Pharmaceutical Research, vol. 33, no. 10, pp. 2517–2529, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Kuter, “Managing thrombocytopenia associated with cancer chemotherapy,” Oncology, vol. 29, no. 4, pp. 282–294, 2015. View at Google Scholar
  12. A. Zeuner, M. Signore, D. Martinetti, M. Bartucci, C. Peschle, and R. De Maria, “Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor,” Cancer Research, vol. 67, no. 10, pp. 4767–4773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Zhang, L. Zhao, J. Liu et al., “Cisplatin induces platelet apoptosis through the ERK signaling pathway,” Thrombosis Research, vol. 130, no. 1, pp. 81–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Cai, Y. Xie, N. M. Davies, M. S. Cohen, and M. L. Forrest, “Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents,” Journal of Pharmaceutical Sciences, vol. 99, no. 6, pp. 2664–2671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Cai, A. A. B. Alhowyan, Q. Yang, W. C. M. Forrest, Y. Shnayder, and M. L. Forrest, “Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates,” Journal of Drug Targeting, pp. 1–10, 2014. View at Google Scholar